Skip to main content
logo
Catalyst Pharmaceuticals, Inc. (CPRX)
Jul 15, 2026 - CPRX was delisted (reason: acquired by Angelini Pharma)
31.49
0.00 (0.00%)
Inactive · Last trade price on Jul 15, 2026

Catalyst Pharmaceuticals Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jul '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Market Cap
3,8552,8592,5231,8011,958697
Market Cap Growth
45.11%13.35%40.10%-8.03%180.80%101.15%
Enterprise Value
3,1022,1532,0081,6661,663509.89
Last Close Price
31.4923.3420.8716.8118.606.77
PE Ratio
18.2013.8915.9326.6824.8018.30
Forward PE
15.6915.4815.3814.1314.9813.97
PEG Ratio
1.261.311.15---
PS Ratio
6.464.855.134.529.144.95
PB Ratio
3.803.003.474.646.523.37
P/TBV Ratio
4.503.614.579.877.733.53
P/FCF Ratio
18.5213.7110.5412.5616.8811.75
P/OCF Ratio
18.5113.7010.5212.5416.8711.55
EV/Sales Ratio
5.203.654.084.187.763.62
EV/EBITDA Ratio
10.147.288.6213.9216.139.70
EV/EBIT Ratio
11.598.3510.2919.1916.339.73
EV/FCF Ratio
14.9010.328.3911.6214.338.59
Debt / Equity Ratio
0.000.000.000.010.010.02
Debt / EBITDA Ratio
0.010.010.010.030.040.07
Debt / FCF Ratio
0.010.010.010.020.030.07
Net Debt / Equity Ratio
-0.74-0.74-0.71-0.35-0.98-0.91
Net Debt / EBITDA Ratio
-2.46-2.39-2.21-1.12-2.86-3.56
Net Debt / FCF Ratio
-3.62-3.39-2.15-0.94-2.54-3.16
Asset Turnover
0.530.600.740.940.700.65
Inventory Turnover
2.333.083.914.634.693.50
Quick Ratio
6.705.684.832.515.367.31
Current Ratio
7.106.085.172.885.577.76
Return on Equity (ROE)
22.50%25.49%29.38%20.75%32.76%20.98%
Return on Assets (ROA)
17.75%19.93%22.38%15.51%26.34%18.26%
Return on Invested Capital (ROIC)
78.90%84.67%63.42%50.65%645.26%161.01%
Return on Capital Employed (ROCE)
27.14%30.55%34.70%24.38%38.52%27.55%
Earnings Yield
5.74%7.20%6.28%3.75%4.03%5.47%
FCF Yield
5.40%7.30%9.48%7.96%5.93%8.51%
Buyback Yield / Dilution
-1.12%-1.85%-9.84%-2.13%-3.32%-1.46%
Total Shareholder Return
-1.12%-1.85%-9.84%-2.13%-3.32%-1.46%
SEC Filings: 10-K · 10-Q